Less Ads, More Data, More Tools Register for FREE

Thursday broker round-up

Thu, 04th Mar 2021 13:25
(Sharecast News) - Weir: Deutsche Bank downgrades to hold with a target price of 2,000p.



Avast: Berenberg reiterates buy with a target price of 680p.

Computacenter: Berenberg reiterates buy with a target price of 3,000p.

K3 Capital Group: Canaccord reiterates buy with a target price of 331p.

Persimmon: Canaccord reiterates buy with a target price of 3,220p.

Mondi: Citigroup reiterates buy with a target price of 2,100p.

Whitbread: JP Morgan upgrades to overweight with a target price of 4,000p.

InterContinental Hotels: JP Morgan upgrades to overweight with a target price of 4,000p.

GSK: Deutsche Bank reiterates sell with a target price of 1,150p.

PZ Cussons: Barclays initiates at overweight with a target price of 300p.

BAE Systems: Barclays reiterates overweight with a target price of 644p.

Plus 500: Liberum reiterates buy with a target price of 1,860p. InterContinental Hotels Plus500 BAE Systems Weir Group Computacenter Glaxosmithkline Persimmon Whitbread Mondi Pz Cussons

Shares in this article

Related News

GSK, Hansoh's targeted cancer drug hits main survival goal in China trial
9 hours ago

GSK, Hansoh's targeted cancer drug hits main survival goal in China trial

* GSK partner Hansoh reports first late-stage data ​for experimental ⁠lung cancer drug

GSK says Ris-Rez meets primary endpoint in phase 3 lung cancer trial
10 hours ago

GSK says Ris-Rez meets primary endpoint in phase 3 lung cancer trial

(Alliance News) - GSK PLC on Friday announced that risvutatug rezetecan has delivered "meaningful" survival data in a "pivotal" trial for advanced or ...

GSK hails 'milestone' drug trial results in China
12 hours ago

GSK hails 'milestone' drug trial results in China

(Sharecast News) - A targeted lung cancer treatment developed by GSK has shown promising results in the latest trials in China, the pharma blue chip c...